Company: INSP
Filing Date: 2025-03-18
Form Type: DEF 14A
Source: 0001140361-25-009249
Chunk: 61

Company: Inspire Medical Systems, Inc.
Filing Date: 2025-03-18
Form: DEF 14A
Chunk 61
---
 | 2,099,874 |     |    4,199,749 |     |           |
| Randall A. Ban       |     |      2024 |     |    1,049,960 |     | 2,099,919 |
| 2023                 |     |   799,743 |     |    1,599,486 |     |           |
| 2022                 |     |   699,882 |     |    1,399,765 |     |           |
| Richard J. Buchholz  |     |      2024 |     |    1,049,960 |     | 2,099,919 |
| 2023                 |     |   799,743 |     |    1,599,486 |     |           |
| 2022                 |     |   699,882 |     |    1,399,765 |     |           |
| Bryan K. Phillips    |     |      2024 |     |    1,049,960 |     | 2,099,919 |
| Carlton W. Weatherby |     |      2024 |     |    1,049,960 |     | 2,099,919 |
| 2023                 |     |   800,112 |     |    1,600,224 |     |           |

| (4) | Amounts reflect cash incentive compensation under our Management Incentive Program for all NEOs, except in the case of Mr. Ban for 2023 and 2022, which amounts reflect earned commissions based on the achievement of sales-related performance metrics. |

| (5) | Represents matching contributions made by the Company under our 401(k) Plan for Messrs. Ban, Buchholz, and Phillips for fiscal 2024. |

| (6) | In connection with the organizational changes discussed above, Mr. Weatherby assumed the role of Chief Strategy and Growth Officer effective December 1, 2024, and Mr. Ban assumed the role of Executive Vice President, Patient Access and Therapy Development effective January 1, 2025. |

| Inspire Medical Systems, Inc. |     | 50 |     | 2025 Proxy Statement |

TABLE OF CONTENTS

| EXECUTIVE COMPENSATION |

Grants of Plan-Based Awards - Fiscal 2024 The following table provides supplemental information relating to grants of plan-based awards